The recent updates about corneal collagen crosslinkingAmr Mounir
This concentrated presentation describes the recent advances in the topic of corneal collagen cross linking with interaction with the most recent publications about this topic.
Basic overview of phaco dynamics along with all the Newer phacoemulsification techniques available in current practice - a video-assisted the presentation
Corneal Cross Linking: Protocols and Literature Review
For sharing:
-- If you found our videos valuable, give us a like --
-- If you know someone who needs to see it, share it:
-- Leave a comment below with your thoughts --
-- Add it to a playlist if you want to watch it later again --
Link: https://youtu.be/rZSjEk3pgco
-- If you like the idea of my channel stay tuned and subscribe--
-- If you would like to check for more information about myself follow
the links on Linkedin and Researchgate:
Linkedin: https://at.linkedin.com/in/tukezban-h...
Researchgate: https://www.researchgate.net/profile/
Instagram: Eye_dr_Tuti
Twitter: https://twitter.com/Eye_DrTuti
The recent updates about corneal collagen crosslinkingAmr Mounir
This concentrated presentation describes the recent advances in the topic of corneal collagen cross linking with interaction with the most recent publications about this topic.
Basic overview of phaco dynamics along with all the Newer phacoemulsification techniques available in current practice - a video-assisted the presentation
Corneal Cross Linking: Protocols and Literature Review
For sharing:
-- If you found our videos valuable, give us a like --
-- If you know someone who needs to see it, share it:
-- Leave a comment below with your thoughts --
-- Add it to a playlist if you want to watch it later again --
Link: https://youtu.be/rZSjEk3pgco
-- If you like the idea of my channel stay tuned and subscribe--
-- If you would like to check for more information about myself follow
the links on Linkedin and Researchgate:
Linkedin: https://at.linkedin.com/in/tukezban-h...
Researchgate: https://www.researchgate.net/profile/
Instagram: Eye_dr_Tuti
Twitter: https://twitter.com/Eye_DrTuti
Keratoconus Through the Eyes of a PatientGary Abud Jr
What would it be like to have a degenerative disease of the cornea? Ultimately resulting in the need for a corneal transplant, keratoconus (KC) breaks down and thins the corneal tissue until vision is impacted in major ways.
One way to optimize Corneal Cross linking (CXL) !! DiyarAlzubaidy
Ophthalmology Lectures: Corneal crosslinking is the only way approved to stop progression of Keratoconus,,let's review the old & new methods of crosslinking
Marsupialization and Evacuation of Epiglottal Mucus Retention Cyst Using AcuP...Lumenis
Marsupialization and Evacuation of Epiglottal Mucus
Retention Cyst Using AcuPulse™ 40WG CO2 Laser System
with FiberLase™ Flexible CO2 Fiber
Case by Marc Remacle, M.D. | CHU Mont-Godinne, University of Louvain, Belgium
By: Thomas M. Proebstle, M.D.
Visit VeinGlobal at http://www.veinglobal.com/ for more presentations and videos on this topic, or for more information on venous disease news, education and research.
Presentation from OIS@ASCRS 2016
John Hendrick, President & CEO
Video Presentation:
https://www.youtube.com/watch?v=c2J1g7HYuek&index=24&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. Acknowledgements:
-Wollensak et al-Effect of cross linking on
porcine cornea
-A J Kanellopoulos et al-Lasik Extra.
-Tobias Koller-UV-X-1000 and UV-X-2000.
-Luis F. Mejia.
3. History:
Theo Seiler, Spoerl and Wollensak.
Since 1998.
Mechanism:
Riboflavin:
Photosensitization.
Photo-protection.
4. Beneficial effects:
Photo-oxidation and chemical bonding.
Collagen fibrils- size.
bonding.
resists digestion.
Increases resistance and induces
stabilization.
9. Accelerated Cross linking:
Reduces time and corneal dehydration.
Coupled with SimLC and Lasik extra.
10. Accelerated Cross-Linking:
A J Kanellopoulos- Athens, Greece-2005.
Wellington Eye Clinic, New Zealand-2007.
Paolo Vinciguerra, Italy-2007-2008.
Switzerland and Bangalore, India.
11. Accelerated Cross linking:
Principle-Bunsen Roscoe law of reciprocity
Experiments:
Wernli et al-40-45 mW/cm2
Hafezi et al-30 mW/cm2
12. Accelerated Cross linking:
IROC device- 9mW/cm2 for 10 mts.
Avedro- various combinations
40mW/cm2 for 2 mts.
30mW/cm2 for 3 mts.
6mW/cm2 for 15 mts.
Time and power vary, irradiation constant-
5.4J/cm2
13. Accelerated Cross linking-Applications:
SimLC- TPG PRK with Cross linking.
The Athens protocol.
-Avedro used at 6mW/cm2 for 15 mts.
Toponeutralization- TNT-NN group,
Bangalore -Avedro used
30mW/cm2 for 4 mts.
14. Accelerated Cross linking:
Lasik extra-A J Kanellopoulos et al
Myopes, special indications.
All hyperopes.
Avedro used 30mW/cm2 for 80 seconds.
15.
16.
17.
18. Other applications:
- AJ Kanellopoulos-Avedro-45mW/cm2 for 3
mts, after astigmatic keratotomy with
femtolaser.
-5-6 hours post Keraflex-Avedro-30mW/cm2
for 3 mts.
-Also being used after Conductive
Keratoplasty.
19. Tobias Koller-8th International Crosslinking
meet-Geneva, Switzerland.
Prospective comparision between:
-Standard and Accelerated Cross linking
-One year results
20. Standard Accelerated
Technique Dresden protocol
UV source UV-X-1000 UV-X-2000
Beam profile Top hat Optimized
Exposure 3mW/cm2 9mW/cm2
Time 30 mts 10 mts
Periphery same 12mW/cm2
24. Results: At 1 year-
Standard Accelerated
BCVA- Gain:
1 line 27.6% 19.9%
2 lines 24.3% 30%
Stable 30.9% 39.9%
BCVA-Loss-1 line: 17% 10.1%
25. Results: At 1 year-
Standard Accelerated
Epithelium 3 days 4.2 days
Haze More
26. Conclusions:
Time and benefits of combining procedures.
Improves work flow
Spin offs:
Corneal endothelial damage.
Sustained effect of Cross linking.
Step in the right direction.